why choose us

First received: October 24, 2022

Clinical Trial: Cannabinoids and Traumatic Brain Injury: A Randomized, Placebo Controlled Trial

Study Status: Completed

Recruit Status: RECRUITING

Condition: Brain Injuries, Traumatic

Study Type: INTERVENTIONAL


Official Title: Cannabinoids and Traumatic Brain Injury: A Randomized, Placebo Controlled Trial

Brief Summary: This is a double-blind, placebo-controlled, parallel group study designed to assess the tolerability and efficacy of fsCBD and bsCBD, compared to a placebo control, to improve cognition and traumatic brain injury-related symptoms.If eligible for the study, subjects will be randomized to receive one of the conditions for 12 weeks.

Read more